Molecular Imaging 2017

NSCLC: Summary

Evidence from the literature on PET for RTP:

feasible with small residual risk for out-field recurrences technical problems to be solved clinical studies needed to demonstrate patients’ benefit

PET as a surrogate end point for treatment efficacy demonstrated under chemotherapy possible after radiotherapy

PET for follow-up of radiation treatment

bears potential for adaptive RT and early assessment of response

PET tracers beyond FDG

Hypoxia imaging and imaging of proliferation possible Use for RT planning to be determined

Slide 41